Essais liés3clinical trials
VillePhiladelphialocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT03235479

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Rimegepant Migraine Phase 3 NCT03235479 Safety and Efficacy Study in Adult Subjects With Acute Migraines COMPLETED
Rimegepant Migraine Phase 3 NCT03461757 Trial in Adult Subjects With Acute Migraines COMPLETED
Rimegepant Migraine Phase 2/3 NCT03266588 Open Label Safety Study in Acute Treatment of Migraine COMPLETED